COMPANY
Company
BUSINESS
Business
NEWS
News
CONTACT
Cn
Jp
En
Platform Business
Platform Business
Sales and Marketing
Sales and Marketing
New Drug Development
New Drug Development
COMPANY
BUSINESS
Platform Business
Platform Business
Sales and Marketing
Sales and Marketing
New Drug Development
New Drug Development
NEWS
CONTACT
Cn
Jp
En
TOP
News
News
2022.12.29
Press Release
Ping An-Shionogi Signs an Agreement with Chia Tai Tianqing Pharmaceutical, a subsidiary of Sino Biopharmaceutical, for Domestic Promotion of Ensitrelvir, a Therapeutic Drug for COVID-19
2022.12.23
Press Release
Ping An-Shionogi Signs a License Agreement for Import and Domestic Distribution of Ensitrelvir, a Therapeutic Drug for COVID-19
2022.11.23
Notice
Shionogi Announces Xocova® (Ensitrelvir Fumaric Acid) Tablets 125mg Approved in Japan for the Treatment of SARS-CoV-2 Infection, under the Emergency Regulatory Approval System
2022.09.29
Notice
Shionogi Announces Achievement of the Primary Endpoint for Ensitrelvir Fumaric Acid (S-217622) in the Phase 3 part of the Phase 2/3 Clinical Trial in Asia
2022.07.04
Notice
Ping An-Shionogi Initiates the Submission of the Preparation Materials for New Drug Application for S-217622, a Therapeutic Drug for COVID-19, in China
2021.06.30
Press Release
Ping An-Shionogi Initiated a New Collaboration with Ping An-Health for Real World Data (RWD) Collection and Analysis Research
Back to Top
Contact
Inquiry Form